EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 0.3% of their position (103.00 shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $896.10 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/13/2025ACC: 0001641172-25-015005
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+103.00
Net shares
Net buyer
$896.10
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
103.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+103.00
Price / share
$8.70
Trade value
$896.10
% of position
0.3%
6/12/2025
38.57K→38.67K
Total
Net shares
+103.00
Net value
$896.10
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2025 | P · Purchase | +103.00 | $8.70 | $896.10 | 0.3% | 38.57K | 38.67K |
| Total | +103.00 | $896.10 | ||||||
Derivative Transactions0
No derivative transactions reported